Contact Us
+91 -9891818024
Multiple Sclerosis (MS) optic atrophy is the cumulative result of repeated inflammatory attacks on the optic nerve, often following episodes of optic neuritis. In MS, the immune system mistakenly attacks the protective myelin sheath around nerve fibres, leading to axonal loss and, over time, optic atrophy. This makes it an important marker of the overall neurodegenerative burden within the central nervous system, and managing it requires a dual focus — suppressing active inflammation and supporting the nerve tissue already affected by the disease.
10+
years Experience
years Experience
5000+
Patients treated
Patients treated
100+
Countries served
Countries served
NABH
Guided facility
Guided facility
Causes
The primary driver of MS optic atrophy is an autoimmune response in which T-cells cross the blood-brain barrier and cause demyelination. Even between acute relapses, a ‘smouldering’ low-grade inflammatory process can continue to affect the nerve, contributing to the progressive thinning seen over time.
Symptoms
Common symptoms include blurred vision, reduced colour perception, and a phenomenon known as Uhthoff’s sign, where vision temporarily worsens with increased body temperature (such as after exercise or a hot shower). Many patients describe their vision as ‘washed out’, with colours appearing less vivid than before, and the central visual field is often most affected, making fine-detail tasks like reading more difficult.
Diagnosis
Neurologists use gadolinium-enhanced MRI to identify active lesions and chronic scarring along the visual pathways. OCT is a valuable tool for measuring the thickness of the retinal nerve fibre layer, which serves as a biomarker for disease progression, while Visual Evoked Potential testing measures the slowed electrical conduction characteristic of demyelination.
Treatment — Stem Cell Therapy
Disease-modifying therapy for MS, managed by a neurologist, remains the priority for controlling the underlying autoimmune process and reducing relapse frequency. Once the disease is stable, stem cell therapy is studied for its potential to support optic nerve tissue affected by earlier inflammatory episodes and help preserve remaining visual function.
Meet The Team
Our Eye Specialists
Dr. Pawan
Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience
Retinal disorders, diabetic retinopathy, and advanced retina procedures. Provides diagnostic evaluation and treatment planning for international patients.
Dr.Pallavee
Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
How Stem Cell Therapy May Help
Mesenchymal Stem Cells (MSCs), typically sourced from bone marrow or umbilical cord tissue, are studied for their potential to support optic nerve tissue health, reduce inflammation, and help preserve remaining visual function. The cells are administered via a minimally invasive procedure — most often through a retrobulbar or intravitreal injection — under the supervision of our ophthalmology and regenerative medicine team. This approach does not restore vision already lost in advanced, complete optic atrophy, but may help support remaining nerve function and quality of life in suitable candidates.
Reviews
What Our Patients Say
Aamit Arora
Your family is very thankful to stem cell cure india for being there for us. The doctors were very understanding and the staff made it a point to see that we were comfortable during the treatment.
Deepak Kumar
From the first time we talked to the team and in all the discussions that followed, the team was really easy to talk to and explained everything clearly. They took the time to understand what was going on
Frequently Asked Questions
Will this treat my MS?
“No. Disease-modifying therapy managed by your neurologist remains essential for controlling MS. Our evaluation focuses specifically on supporting optic nerve tissue affected by past episodes.”
Does Uhthoff’s sign mean permanent damage?
“No — Uhthoff’s sign is typically a temporary, reversible worsening of vision with heat or exertion, and is not itself a sign of new permanent damage.”
When is stem cell therapy considered for MS-related optic atrophy?
“Only once your neurologist confirms your MS is stable, and specifically to support residual optic nerve tissue — not as a treatment for the underlying autoimmune disease.”
